About the Company
Endo is a specialty pharmaceutical company committed to helping everyone it serves live their best life through the delivery of quality, life-enhancing therapies. Its decades of proven success come from a global team of passionate employees collaborating to bring the best treatments forward. Together, it boldly transforms insights into treatments benefiting those who need them, when they need them.
Exchange
NASDAQ
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ENDP News
Endo Inc. Announces Major Financing Move with $1.65 Billion in New Credit Facilities Amid Restructuring
Endo, Inc., a newly established entity, recently unveiled plans to secure new senior secured credit facilities totaling $1.65 ...
Endo International PLC ENDP
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Endo Announces Confirmation of Plan of Reorganization
DUBLIN, March 19, 2024 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) ("Endo" or the "Company") today announced that the United States Bankruptcy Court for the Southern District of New York has ...
Endo Intl's Par Pharma Recalls Treprostinil Injection For Silicone Particulates
(RTTNews) - Dublin, Ireland -based Endo International plc announced that its operating company Par Pharmaceutical, Inc. is recalling one lot of Treprostinil Injection 20mg/20mL (1mg/mL) to the ...
Endo International plc: Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS®
DUBLIN, March 26, 2024 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., launched ibuprofen-famotidine 800 mg/26.6 ...
Endo International plc (ENDP)
Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...
Endo International plc: Endo Announces Confirmation of Plan of Reorganization
Anticipates Completing Financial Restructuring as Early as Late April 2024 DUBLIN, March 19, 2024 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) ("Endo" or the "Company") today announced that ...
Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS®
DUBLIN, March 26, 2024 /CNW/ -- Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., launched ibuprofen-famotidine 800 mg/26.6 mg ...
Endo Announces Confirmation of Plan of Reorganization
DUBLIN, March 19, 2024 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) ("Endo" or the "Company") today announced that the United States Bankruptcy Court for the Southern District of New York ...
Loading the latest forecasts...